Ruth J. Mayer

5.4k total citations · 1 hit paper
71 papers, 3.5k citations indexed

About

Ruth J. Mayer is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Ruth J. Mayer has authored 71 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 17 papers in Oncology and 10 papers in Cancer Research. Recurrent topics in Ruth J. Mayer's work include Peptidase Inhibition and Analysis (8 papers), Cell Adhesion Molecules Research (8 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers). Ruth J. Mayer is often cited by papers focused on Peptidase Inhibition and Analysis (8 papers), Cell Adhesion Molecules Research (8 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers). Ruth J. Mayer collaborates with scholars based in United States, United Kingdom and Spain. Ruth J. Mayer's co-authors include Lisa A. Marshall, David J. Candy, Lawrence Que, Ruth Tal‐Singer, William MacNee, A. Lawrence Roe, Bruce E. Miller, Àlvar Agustí, Edwin K. Silverman and David A. Lomas and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Ruth J. Mayer

70 papers receiving 3.4k citations

Hit Papers

Persistent Systemic Inflammation is Associated with Poor ... 2012 2026 2016 2021 2012 200 400 600

Peers

Ruth J. Mayer
Jules A. Shafer United States
Debkumar Pain United States
Denis J. Schrier United States
Ross B. Mikkelsen United States
Ruth J. Mayer
Citations per year, relative to Ruth J. Mayer Ruth J. Mayer (= 1×) peers Robert N. Young

Countries citing papers authored by Ruth J. Mayer

Since Specialization
Citations

This map shows the geographic impact of Ruth J. Mayer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruth J. Mayer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruth J. Mayer more than expected).

Fields of papers citing papers by Ruth J. Mayer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruth J. Mayer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruth J. Mayer. The network helps show where Ruth J. Mayer may publish in the future.

Co-authorship network of co-authors of Ruth J. Mayer

This figure shows the co-authorship network connecting the top 25 collaborators of Ruth J. Mayer. A scholar is included among the top collaborators of Ruth J. Mayer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruth J. Mayer. Ruth J. Mayer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Busch‐Petersen, Jakob, Donald C. Carpenter, Miriam Burman, et al.. (2017). Danirixin: A Reversible and Selective Antagonist of the CXC Chemokine Receptor 2. Journal of Pharmacology and Experimental Therapeutics. 362(2). 338–346. 39 indexed citations
2.
Yang, Lucy, Joseph Cheriyan, David D. Gutterman, et al.. (2016). Mechanisms of Vascular Dysfunction in COPD and Effects of a Novel Soluble Epoxide Hydrolase Inhibitor in Smokers. CHEST Journal. 151(3). 555–563. 50 indexed citations
3.
Yonchuk, John, Edwin K. Silverman, Russell P. Bowler, et al.. (2015). Circulating Soluble Receptor for Advanced Glycation End Products (sRAGE) as a Biomarker of Emphysema and the RAGE Axis in the Lung. American Journal of Respiratory and Critical Care Medicine. 192(7). 785–792. 72 indexed citations
4.
Tudhope, Susan J., Tricia Finney‐Hayward, Andrew G. Nicholson, et al.. (2007). Different Mitogen-Activated Protein Kinase-Dependent Cytokine Responses in Cells of the Monocyte Lineage. Journal of Pharmacology and Experimental Therapeutics. 324(1). 306–312. 53 indexed citations
5.
Szulakowski, Patryk, Luis A. Jiménez, Kenneth Donaldson, et al.. (2006). The Effect of Smoking on the Transcriptional Regulation of Lung Inflammation in Patients with Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 174(1). 41–50. 141 indexed citations
6.
Mayer, Ruth J., Brian Bolognese, David G. Smith, et al.. (2002). CD23 shedding: requirements for substrate recognition and inhibition by dipeptide hydroxamic acids. Inflammation Research. 51(2). 85–90. 8 indexed citations
7.
Khandekar, Sanjay S., et al.. (2001). Expression and Purification of Stable 33-kDa Soluble Human CD23 Using the Drosophila S2 Expression System. Protein Expression and Purification. 22(2). 330–336. 4 indexed citations
8.
Mayer, Ruth J., et al.. (2001). Metalloprotease inhibitor‐mediated inhibition of mouse immunoglobulin production. Immunology. 102(3). 281–288. 2 indexed citations
9.
Davenpeck, Kelly L., Mary Brummet, Sherry A. Hudson, Ruth J. Mayer, & Bruce S. Bochner. (2000). Activation of Human Leukocytes Reduces Surface P-Selectin Glycoprotein Ligand-1 (PSGL-1, CD162) and Adhesion to P-Selectin In Vitro. The Journal of Immunology. 165(5). 2764–2772. 109 indexed citations
10.
Bailey, Stuart, Brian Bolognese, Andrew Faller, et al.. (1999). Selective inhibition of low affinity IgE receptor (CD23) processing: P1′ bicyclomethyl substituents. Bioorganic & Medicinal Chemistry Letters. 9(21). 3165–3170. 5 indexed citations
11.
Marshall, Lisa A., Michael Hansbury, Brian Bolognese, et al.. (1998). Inhibitors of the p38 Mitogen-Activated Kinase Modulate IL-4 Induction of Low Affinity IgE Receptor (CD23) in Human Monocytes. The Journal of Immunology. 161(11). 6005–6013. 31 indexed citations
12.
Bailey, Stuart, Brian Bolognese, Derek R. Buckle, et al.. (1998). Hydroxamate-based inhibitors of low affinity IgE receptor (CD23) processing. Bioorganic & Medicinal Chemistry Letters. 8(1). 23–28. 12 indexed citations
13.
Sung, Chiu-Mei, et al.. (1998). β-Lactams SB 212047 and SB 216754 Are Irreversible, Time-Dependent Inhibitors of Coenzyme A-Independent Transacylase. Molecular Pharmacology. 53(2). 322–329. 13 indexed citations
14.
Christie, Gary, A. D. Barton, Brian Bolognese, et al.. (1997). IgE secretion is attenuated by an inhibitor of proteolytic processing of CD23 (FcεRII). European Journal of Immunology. 27(12). 3228–3235. 39 indexed citations
15.
Mayer, Ruth J., et al.. (1995). Hyperkultur: Zur Fiktion DES Conputerzeitalters. De Gruyter eBooks. 2 indexed citations
16.
Amegadzie, Bernard Y., et al.. (1993). High-level production of biologically active human cytosolic phospholipase A2 in baculovirus-infected insect cells. Gene. 128(2). 307–308. 15 indexed citations
17.
Louis-Flamberg, Pearl, Catherine E. Peishoff, Deborah Bryan, et al.. (1990). Slow binding inhibition of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. Biochemistry. 29(17). 4115–4120. 11 indexed citations
18.
Mayer, Ruth J., Christine Debouck, & Brian W. Metcalf. (1988). Purification and properties of the catalytic domain of human 3-hydroxy-3-methylglutaryl-CoA reductase expressed in Escherichia coli. Archives of Biochemistry and Biophysics. 267(1). 110–118. 21 indexed citations
19.
Roe, A. Lawrence, David J. Schneider, Ruth J. Mayer, et al.. (1984). X-ray absorption spectroscopy of iron-tyrosinate proteins. Journal of the American Chemical Society. 106(6). 1676–1681. 230 indexed citations
20.
Mayer, Ruth J. & John H. Walker. (1980). Immunochemical methods in the biological sciences : enzymes and proteins. Academic Press eBooks. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026